RxDoctor Payments Data

Kelly Keniray

Family · Canton, OHNPI 1427560440

Payments from drug & device makers

$4,764in general payments, 2019–2025

Across 271 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$741
  • AbbVie$651
  • Novo Nordisk$591
  • Lilly USA, LLC$548
  • Astellas Pharma US Inc$376
  • Bayer$235
  • plus $2K from 22 others

What the payments were for

  • Food & beverage$4,67498%
  • Education$902%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,764 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin20$16,827
OzempicSemaglutide17$15,990
FarxigaDapagliflozin Propanediol21$13,178
VascepaIcosapent Ethyl16$8,631
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,313
MyrbetriqMirabegron14$5,928
BrilintaTicagrelor11$5,276
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$4,821
Pantoprazole Sodium72$1,283
Ezetimibe28$1,241
Colestipol Hcl14$1,118
Rosuvastatin Calcium83$1,068
Albuterol Sulfate HfaAlbuterol Sulfate40$952
Gabapentin51$919
Atorvastatin Calcium126$904

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Brilinta$741$18,45432 claims
Boehringer IngelheimJardiance$194$16,82720 claims
Novo NordiskOzempic$591$15,99017 claims
GSKTrelegy Ellipta, Anoro Ellipta$12$13,13426 claims
Astellas Pharma US IncMyrbetriq$376$5,92814 claims
AbbVieSynthroid$651$72113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,812 family providers in Ohio.

Other family in Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →